Premium
Immunohistochemical detection of SATB1 is independent of thyroid cancer differentiation
Author(s) -
Murono Shigeyuki,
Tsuji Akira,
Endo Kazuhira,
Kondo Satoru,
Wakisaka Naohiro,
Yoshizaki Tomokazu
Publication year - 2013
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.23992
Subject(s) - medicine , thyroid cancer , thyroid , anaplastic thyroid cancer , immunohistochemistry , cancer , follicular thyroid cancer , oncology , pathology , cancer research , papillary thyroid cancer
Objectives/Hypothesis The association of special AT‐rich binding protein 1 ( SATB1 ) with a poor prognosis in various cancers has been reported. However, this association is controversial. SATB1 expression in aggressive types of thyroid cancer has not been reported to date. Study Design Retrospective. Methods SATB1 expression was immunohistochemically investigated in 35 papillary thyroid cancers, one follicular thyroid cancer, six poorly differentiated thyroid cancers, and two anaplastic thyroid cancers. Results SATB1 expression was observed in none of two anaplastic thyroid cancers, one of six poorly differentiated thyroid cancers, and nine of 36 well‐differentiated thyroid cancers. SATB1 expression was not significantly associated with any high‐risk group‐related clinicopathologic factors in well‐differentiated thyroid cancer. Survival was not associated with SATB1 expression. Conclusions SATB1 expression is independent of thyroid cancer differentiation, as well as high‐risk‐related factors. SATB1 may not play a role in the aggressiveness of thyroid cancer. Level of Evidence N/A Laryngoscope , 123:2909–2912, 2013